Evidence map›Paper›PMID 40729057›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2025

Investigations of Cu2ONPs - Orange Peels: Biosynthesis, Characterization, and Anticancer Activity on a Cytotoxic Breast Cancer Cell Line.

Khalidah Khalaf Jabbar, Salim Oudah Mezan, Mohamed Bouaziz

Abstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Khalidah Khalaf JabbarLaboratory of Electrochemistry and Environment, National School of Engineers of Sfax BP "1173" 3038, University of Sfax, Sfax, Tunisia.
Salim Oudah MezanGama Tec Lab, University Street, Ministry of Education, Open Educational College, Studies Centre Muthanna, Republic of Iraq.
Mohamed BouazizLaboratory of Electrochemistry and Environment, National School of Engineers of Sfax BP "1173" 3038, University of Sfax, Sfax, Tunisia.ORCID 0000-0001-9107-7027

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe study aimed to evaluate the efficacy of nanocomposites extracted from orange peels in targeting and combating MCF-7 cells.

methodsWe characterized the nanoparticles using XRD, FTIR, SEM, and GC-MS, and evaluated their cytotoxicity and activity using the MTT colorimetric assay and double staining technique.

resultsThe obtained results showed that the nanoparticles ranged from 19 to 66 nanometers in size and contained active compounds in the range of 4,000-500 cm⁻¹. However, the XRD sizes of the crystalline nanoparticles ranged from 15 to 23 nm. Orange peel contains important compounds such as octanal, 1, 6-octadien-3-ol, 3, 7-dimethyl, and limonene. At 800 mg/ml, DPPH can act as a strong antioxidant and reduce free radicals by 78.29%. The addition of the molecules resulted in a trace amount of 3.99%, a viability of 74.671%, and a half-maximal inhibitory concentration of 43.75 g/mL for the cell line. The compatibility with the low concentration effectively repaired the damaged cells.

conclusionsWe expect the present study to provide important insights into the influence of molecular structure on anti-cancer action.

Indexed as

Antineoplastic AgentsBreast NeoplasmsCitrus sinensisCopperFruitNanocompositesPlant ExtractsAntioxidantsCell ProliferationFemaleHumansMCF-7 CellsTumor Cells, CulturedX-Ray DiffractionAntineoplastic AgentsAntioxidantsCopperPlant Extractscuprous nanoparticles -orange peelsDAPIMCF-7 cell line

Identifiers

PMID40729057
PMCPMC12507067

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.